Literature DB >> 19505555

American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages.

Tomonaga Ichikawa1, Jinqing Li, Prakash Nagarkatti, Mitzi Nagarkatti, Lorne J Hofseth, Anthony Windust, Taixing Cui.   

Abstract

AIM OF THE STUDY: Ginseng has been used as general tonic for thousands of years in Asia and becomes a popular herbal medicine all over the world. However, the cellular and molecular mechanisms underlying its benefit effects are less explored. Thus, we investigated the effect of a crude extract from Panax quinquefolius (American ginseng) on suppression of pro-inflammatory responses in macrophages with a focus on signal transducer and activator of transcription (STAT) signaling.
MATERIALS AND METHODS: The crude extract of American ginseng that was supplied by the National Research Council of Canada, Institute for National Measurement Standards (NRCC-INMS) was freshly solvated in Dulbecco's Modified Eagle Medium (DMEM) prior to each experiment. RAW264.7 cells, a murine macrophage cell line, were exposed to lipopolysaccharide (LPS) to induce inflammatory responses such as expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2). Proteins were measured by Western blot and mRNA expression was determined by quantitative real-time PCR (Q-PCR). Activator protein 1 (AP-1)-, nuclear factor-kappaB (NF-kappaB)- and STAT-mediated transcriptional activities were investigated using luciferase reporter constructs.
RESULTS: American ginseng inhibited LPS-induced iNOS expression; however, it did not affect LPS-induced COX2 expression. While American ginseng had no impact on LPS-induced activation of AP-1 or NF-kappaB pathways, it dramatically inhibited LPS-induced activation of STAT signaling. Moreover, American ginseng and AG490, an inhibitor of STAT cascade, synergistically suppressed the LPS-induced iNOS expression.
CONCLUSION: American ginseng selectively inhibits the expression of iNOS via suppression of STAT cascade but not NF-kappaB and AP-1 pathways in inflamed macrophages. Such a preferential suppression of STAT/iNOS cascade by American ginseng might have therapeutic potential for inflammatory diseases with over-activation of iNOS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505555      PMCID: PMC2790430          DOI: 10.1016/j.jep.2009.05.032

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  35 in total

Review 1.  Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes.

Authors:  S Cuzzocrea; D Salvemini
Journal:  Kidney Int       Date:  2007-01-03       Impact factor: 10.612

Review 2.  Inflammation, cancer, and targets of ginseng.

Authors:  Lorne J Hofseth; Michael J Wargovich
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

3.  KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells.

Authors:  Sin-Aye Park; Eun-Hee Kim; Hye-Kyung Na; Young-Joon Surh
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

4.  Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor.

Authors:  Kar Wah Leung; Fung Ping Leung; Yu Huang; Nai Ki Mak; Ricky N S Wong
Journal:  FEBS Lett       Date:  2007-04-30       Impact factor: 4.124

Review 5.  The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.

Authors:  Guillermo Salinas; Umamahesh C Rangasetty; Barry F Uretsky; Yochai Birnbaum
Journal:  J Cardiovasc Pharmacol Ther       Date:  2007-06       Impact factor: 2.457

6.  Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway.

Authors:  Luis Villacorta; Jifeng Zhang; Minerva T Garcia-Barrio; Xi-lin Chen; Bruce A Freeman; Yuqing E Chen; Taixing Cui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-27       Impact factor: 4.733

Review 7.  Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness.

Authors:  Chong-Zhi Wang; Sangeeta R Mehendale; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2007       Impact factor: 4.667

Review 8.  Cross-talk between NO and arachidonic acid in inflammation.

Authors:  Sofia Mariotto; Ylenia Suzuki; Tiziana Persichini; Marco Colasanti; Hisanori Suzuki; Orazio Cantoni
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 9.  Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide?

Authors:  V C Mathrani; N J Kenyon; A Zeki; J A Last
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein.

Authors:  Hye Gwang Jeong; Yuba Raj Pokharel; Eun Hee Han; Keon Wook Kang
Journal:  Biochem Biophys Res Commun       Date:  2007-05-21       Impact factor: 3.575

View more
  17 in total

1.  A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.

Authors:  Shuai Liu; Jiaju Lv; Liping Han; Tomonaga Ichikawa; Wenjuan Wang; Siying Li; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  Biochem Biophys Res Commun       Date:  2012-03-01       Impact factor: 3.575

2.  A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms.

Authors:  Deepak Poudyal; Phuong Mai Le; Tia Davis; Anne B Hofseth; Alena Chumanevich; Alexander A Chumanevich; Michael J Wargovich; Mitzi Nagarkatti; Prakash S Nagarkatti; Anthony Windust; Lorne J Hofseth
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-31

3.  An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes.

Authors:  Jinqing Li; Tomonaga Ichikawa; Yu Jin; Lorne J Hofseth; Prakash Nagarkatti; Mitzi Nagarkatti; Anthony Windust; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2010-05-04       Impact factor: 4.360

4.  Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy.

Authors:  Chen Qu; Bin Li; Yimu Lai; Hechu Li; Anthony Windust; Lorne J Hofseth; Mitzi Nagarkatti; Prakash Nagarkatti; Xing Li Wang; Dongqi Tang; Joseph S Janicki; Xingsong Tian; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2015-04-14       Impact factor: 4.360

Review 5.  Ginsenosides from American ginseng: chemical and pharmacological diversity.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Phytochemistry       Date:  2011-03-09       Impact factor: 4.072

6.  American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway.

Authors:  Qi Wu; Wenjuan Wang; Siying Li; Prakash Nagarkatti; Mitzi Nagarkatti; Anthony Windust; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2012-10-04       Impact factor: 4.360

7.  Immunomodulatory effect of a formula developed from American ginseng and Chinese jujube extracts in mice.

Authors:  Zhuo-ping Yu; Dong-dong Xu; Lai-feng Lu; Xiao-dong Zheng; Wei Chen
Journal:  J Zhejiang Univ Sci B       Date:  2016-02       Impact factor: 3.066

8.  STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells.

Authors:  Po-Wen Liu; Mei-Fang Chen; Andy Po-Yi Tsai; Tony J F Lee
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.

Authors:  Yi Tan; Tomonaga Ichikawa; Jinqing Li; Qiusheng Si; Huaitao Yang; Xiangbai Chen; Curtis S Goldblatt; Colin J Meyer; Xiaokun Li; Lu Cai; Taixing Cui
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

10.  The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis.

Authors:  Joo Hyun Jung; Il Gyu Kang; Dae Young Kim; You Jin Hwang; Seon Tae Kim
Journal:  J Ginseng Res       Date:  2013-04       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.